by Richard Cruse | Feb 6, 2025 | Press releases
ProFactor Pharma Ltd. (PFP), a UK biotech company, is pleased to announce it has been awarded a SMART: SCOTLAND grant from Scottish Enterprise. This grant has been awarded to perform a preclinical Proof-of-Concept study of a novel approach to significantly improve the...
by Richard Cruse | Apr 11, 2024 | Events
On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is “Equitable access for all: recognizing all bleeding disorders”. The World Federation...
by Richard Cruse | Jul 10, 2023 | News
ProFactor Pharma Ltd (PFP) is excited to welcome Eugenia Wachters, who joined the company as Chief Operating Officer on 1st July 2023. Eugenia will be responsible for leading the company’s business operations, working closely with the PFP Executive team and Board...
by Richard Cruse | Apr 19, 2023 | News
The World Federation of Hemophilia (WFH) have set April 17, 2023 as World Hemophilia Day. The theme of the event this year is “Access for All: Prevention of bleeds as the global standard of care”. Building on last year’s theme, the call to action for the community in...
by Richard Cruse | Sep 20, 2022 | News
ProFactor Pharma is pleased to announce completion of a further investment round. The investment will enable PFP to progress the company’s clinical stage Recombinant Human Factor VIII to market and to engage with commercial licensing opportunities. The funding...
